Telehealth & Digital Health

Federal cuts are pushing 450,000 New Yorkers off the Essential Plan. Here’s what you need to know to avoid a coverage gap and find a new plan now.

At EHA 2026, Parexel isn't just presenting data; it's unveiling a bold new strategy to fix a broken system and accelerate life-saving blood cancer drugs.

New clinical data suggests Cullinan Therapeutics' cancer-fighting tech could offer durable, treatment-free remission for severe RA and lupus patients.

As AI fatigue hits markets, one sector sees a real breakthrough. Taiwan's TFC is using AI to boost IVF success, offering new hope to infertile couples.

One in six people globally faces infertility, yet a pervasive stigma silences their struggle. A worldwide movement is now uniting millions to demand change.

A new partnership between software specialist Cosylab and hardware innovator Heron aims to overcome the final hurdles in deploying a promising cancer therapy worldwide.

A UK firm's regulatory milestone is more than just compliance; it's a strategic masterclass in building the resilient systems needed to fight food allergies.

A groundbreaking partnership between Servier and n-Lorem Foundation blends pharma R&D muscle with non-profit agility to develop ASO therapies for the rarest of diseases.

A new study by SciBase and Castle Biosciences is testing technology to predict atopic dermatitis flares, promising a shift from reactive care to patient control.

Carestream's new Lux HD detectors blend high-res imaging, AI, and rugged design to boost diagnostics, streamline workflows, and challenge market rivals.

Takeda seeks FDA approval for its gut-focused drug ENTYVIO in children, a major step toward a new era of treatment for the rising tide of pediatric IBD.

A novel TYK2 inhibitor that can enter the central nervous system has begun human trials, signaling a new frontier for treating diseases like MS and lupus.

Asante and WesternU launch a strategic partnership to embed medical students in the Rogue Valley, tackling physician shortages with a 'grow your own' model.

Medmovie's move to a browser-based platform for its cardiac visuals isn't just a tech upgrade; it's a strategic push to democratize health literacy.

New long-term data for masitinib shows a near doubling of 5-year survival for ALS patients, with many maintaining quality of life. Is this the turning point?

Arlow's new platform moves beyond reactive crisis management, using a hybrid AI and human-led system to proactively manage the entire aging journey.

A silent disease affects 54 million Americans and is set to cost $95 billion by 2030. Now, 33 states are taking action against the osteoporosis epidemic.

Mosaic Clinical Technologies launches an AI-native platform that assists radiologists in real time, aiming to boost capacity and fight burnout in a strained field.

Dana-Farber's historic $50M Yawkey grant funds more than a building; it fuels a new era of integrated research and patient-centric cancer treatment.

A new FDA-cleared laser offers a drug-free option for millions with tennis elbow. But does the science justify the cost and will patients have access?